Robert Schlaberg

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. pmc A systematic approach for discovering novel, clinically relevant bacteria
    Robert Schlaberg
    University of Utah School of Medicine, Salt Lake City, Utah, USA
    Emerg Infect Dis 18:422-30. 2012
  2. doi request reprint Verification of performance specifications for a US Food and Drug Administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assay
    Robert Schlaberg
    Department of Pathology, University of Utah School of Medicine, Salt Lake City, 84108, USA
    Arch Pathol Lab Med 136:20-5. 2012
  3. doi request reprint Susceptibility profiles of nocardia isolates based on current taxonomy
    Robert Schlaberg
    ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, Utah, USA
    Antimicrob Agents Chemother 58:795-800. 2014
  4. doi request reprint tcdA As a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficile
    Brianne Couturier
    Associated Regional and University Pathologists ARUP Laboratories, Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA
    J Clin Lab Anal 27:171-6. 2013
  5. pmc Sequencing-based genotyping of mixed human papillomavirus infections by use of RipSeq software
    Keith D Tardif
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA
    J Clin Microbiol 51:1278-80. 2013
  6. pmc Isolation and identification of Kroppenstedtia eburnea isolates from multiple patient samples
    Adam P Barker
    University of Utah School of Medicine, Salt Lake City, UT, USA
    J Clin Microbiol 50:3391-4. 2012

Collaborators

Detail Information

Publications6

  1. pmc A systematic approach for discovering novel, clinically relevant bacteria
    Robert Schlaberg
    University of Utah School of Medicine, Salt Lake City, Utah, USA
    Emerg Infect Dis 18:422-30. 2012
    ....
  2. doi request reprint Verification of performance specifications for a US Food and Drug Administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assay
    Robert Schlaberg
    Department of Pathology, University of Utah School of Medicine, Salt Lake City, 84108, USA
    Arch Pathol Lab Med 136:20-5. 2012
    ..Advances in technology and lower costs have moved molecular diagnostic tests formerly performed for research purposes only into much wider use in clinical microbiology laboratories...
  3. doi request reprint Susceptibility profiles of nocardia isolates based on current taxonomy
    Robert Schlaberg
    ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, Utah, USA
    Antimicrob Agents Chemother 58:795-800. 2014
    ....
  4. doi request reprint tcdA As a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficile
    Brianne Couturier
    Associated Regional and University Pathologists ARUP Laboratories, Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA
    J Clin Lab Anal 27:171-6. 2013
    ..We assessed the use of tcdA as the molecular target in the illumigene® C. difficile loop-mediated amplification assay in detecting a wide variety of C. difficile strains including those with tcdA deletions...
  5. pmc Sequencing-based genotyping of mixed human papillomavirus infections by use of RipSeq software
    Keith D Tardif
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA
    J Clin Microbiol 51:1278-80. 2013
    ..RipSeq Mixed provided rapid, sequencing-based HPV typing for single-type infections and coinfections with 2 types...
  6. pmc Isolation and identification of Kroppenstedtia eburnea isolates from multiple patient samples
    Adam P Barker
    University of Utah School of Medicine, Salt Lake City, UT, USA
    J Clin Microbiol 50:3391-4. 2012
    ....